Refractory Status Epileptics Drugs Market in North America Leads with High FDA Approval Rate.
The global Refractory Status Epileptics Drugs Market is experiencing steady growth, driven by the rising incidence of refractory status epilepticus (RSE), a severe neurological emergency characterized by persistent seizures unresponsive to initial treatments like benzodiazepines. RSE affects up to 40% of status epilepticus cases, often linked to acute symptomatic etiologies such as infections...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek